intoxicant.wiki2catechol4school
Layout
Opioid

Codeine

Also called Lean, Purple Drank, Syrup

Why a "revision used" link? Anyone can edit Wikipedia at any time, so the article you open today may not say what it said when we read it. This link opens the exact version we read on 24 October 2026, frozen as it was. It is the only way to check that every quote on this page matches its source word for word. Newer versions may correct or change things. When we re-check this page against a newer version, the edit log records it. How we cite

Common dose · Oral100–150 mg PW
Onset30–45 minutes PW
Total3–6 hours PW

Dosage

When sources disagree, both rows are shown as published. Nothing is averaged or merged.

Oral

SourceThresholdLightCommonStrongHeavy
PsychonautWiki30 mg PW50–100 mg PW100–150 mg PW150–200 mg PW200 mg+ PW
TripSit–50–100 mg TS100–150 mg TS–150–200 mg TS

NOTE: The ceiling effect differs from person to person, but it seems to fall between 400-600mg TS

TripSit dose text

TripSit's factsheet also states its doses as text.

Oral Light: 50-100mg Common: 100-150mg Heavy: 150-200mg | NOTE: The ceiling effect differs from person to person, but it seems to fall between 400-600mg TS

What dose are you on? (self-reported, unverified)
Read this first. These numbers come from anonymous visitors typing in a box. Nobody checks them. People misjudge, mistype, troll, or take untested products of unknown strength. They are not a dose guide and never override the sourced table above. They exist only so the sourced ranges can be compared with what people say they take. If you are deciding what to take, use the sourced table, start low, and read the risks section.
Running self-reports

No reports yet.

Reports are anonymous, one per browser per day per route. Counts under 20 are shown but marked as too few to mean anything. Until accounts launch, reports stay in this browser only.

Duration

Route · sourceOnsetCome-upPeakOffsetTotalAfter-effects
Oral · PsychonautWiki30–45 minutes PW1–2 hours PW3–5 hours PW2–4 hours PW3–6 hours PW–

TripSit factsheet

Onset
30-45 minutes TS
Duration
3-6 hours TS
Aftereffects
1-12 hours TS

Mixing

Acute combinations: what happens when these are taken close together. Entries backed by a medical journal or agency are listed first.

Backed by medical journals

Awaiting sourcePeer-reviewed reports on acute combinations, from PubMed and the journals the harm reduction sites cite.

PsychonautWiki also lists dangerous combinations shared across a whole group (opioids) in a table this page does not copy. Read that list on PsychonautWiki.

TripSit combination chart

TripSit rates each pairing. Only pairings with a number carry a citation from TripSit. See the whole chart, with TripSit's note for every pairing.

Caution

Low Risk & Synergy

Low Risk & No Synergy

Risks and toxicity

Codeine has a low toxicity relative to dose. As with all opioids, long-term effects can vary but can include diminished libido, apathy and memory loss. Some people may also have an allergic reaction to codeine, such as the swelling of skin and rashes. It is also potentially lethal when mixed with depressants like alcohol or benzodiazepines.[15] PW

It is strongly recommended that one use harm reduction practices when using this drug. PW

Tolerance and addiction potential

As with other opioids, the chronic use of codeine can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal symptoms may occur if a person suddenly stops their usage. PW

Tolerance to many of the effects of codeine develops with prolonged and repeated use. The rate at which this occurs develops at different rates for different effects, with tolerance to the constipation-inducing effects developing particularly slowly for instance. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). Codeine presents cross-tolerance with all other opioids, meaning that after the consumption of codeine all opioids will have a reduced effect. PW

TripSit factsheet

Avoid
People seeking codeine experiences from medications that contain acetaminophen (paracetamol) may be putting themselves at risk for acetaminophen-related complications such as liver damage.[2–6] TS
Warning
You must only use this drug orally due to the risk of severe immune system responses. It needs to pass through the liver to be activated anyway so IV, nasal, plugging etc do not offer an advantage[2–6] TS

Testing

Marquis
Very dark purple TS

Effects

EuphoriaDry MouthMood liftItchinessRelaxantConstipationPupil constrictionAnalgesia TS

Overview

Codeine (also known as 3-Methylmorphine) is a naturally-occurring opioid substance of the morphinan class found in extracts of the poppy, particularly Papaver bracteatum. Members of this group produce effects such as sedation, cough suppression, and euphoria when administered.[1] PW

Codeine is a weaker opioid used to treat mild to moderate pain and to relieve cough. In many countries it is available over the counter in combination with paracetamol, which can easily be extracted to retrieve near-pure codeine. For this reason, it is used widely as a recreational opioid. It is metabolised into morphine in the body at a rate of 5% mg for mg.[2–6] TS

Codeine is an opiate and prodrug of morphine mainly used to treat pain, coughing, and diarrhea. It is commonly used as a recreational drug. It is found naturally in the sap of the opium poppy, Papaver somniferum. It is typically used to treat mild to moderate degrees of pain. Greater benefit may occur when combined with paracetamol (acetaminophen) as codeine/paracetamol or a nonsteroidal anti-inflammatory drug (NSAID) such as aspirin or ibuprofen. Evidence does not support its use for acute cough suppression in children. In Europe, it is not recommended as a cough medicine for those under 12 years of age. It is generally taken orally. It usually starts working after half an hour, with maximum effect at two hours. Its effects last for about four to six hours. Codeine exhibits abuse potential similar to other opioid medications, including a risk of addiction and overdose.[7–10] WP⚠ Wikipedia itself has flagged this text: failed verification.

Common side effects include nausea, vomiting, constipation, itchiness, lightheadedness, and drowsiness. Serious side effects may include breathing difficulties and addiction. Whether it can be used safely during pregnancy is unclear. Care should be used during breastfeeding, as it may result in opiate toxicity in the baby. Its use as of 2016 is not recommended for children. Codeine works by being broken down by the liver into morphine; how quickly this occurs depends on a person's genetics.[7][11] WP

Codeine was discovered in 1832 by Pierre Jean Robiquet. In 2013, about 361,000 kg (795,000 lb) of codeine were produced while 249,000 kg (549,000 lb) were used, which made it the most commonly taken opiate. It is on the World Health Organization's List of Essential Medicines. Codeine occurs naturally and makes up about 2% of opium.[12][13][14] WP

History

History

Codeine, or 3-methylmorphine, is an alkaloid found in the opium poppy, Papaver somniferum var. album, a plant in the family Papaveraceae. Opium poppy has been cultivated and utilized throughout human history for a variety of medicinal (analgesic, anti-tussive and anti-diarrheal) and hypnotic properties linked to the diversity of its active components, which include morphine, codeine and papaverine. WP

Codeine is found in concentrations of 1% to 3% in opium prepared by the latex method from unripe pods of Papaver somniferum. The name codeine is derived from the Ancient Greek κώδεια (kṓdeia, "poppy head"). The relative proportion of codeine to morphine, the most common opium alkaloid at 4% to 23%, tends to be somewhat higher in the poppy straw method of preparing opium alkaloids. WP

Until the beginning of the 19th century, raw opium was used in diverse preparations known as laudanum (see Thomas de Quincey's Confessions of an English Opium-Eater, 1821) and paregoric elixirs, several which were popular in England since the beginning of the 18th century; the original preparation seems to have been elaborated in Leiden, the Netherlands around 1715 by a chemist Jakob Le Mort; in 1721 the London Pharmacopoeia mentions an Elixir Asthmaticum, replaced by the term Elixir Paregoricum ("pain soother") in 1746. WP

The progressive isolation of opium's several active components opened the path to improved selectivity and safety of the opiates-based pharmacopeia. WP

Morphine had already been isolated in Germany by Friedrich Sertürner in 1804. Codeine was first isolated in 1832 in France by Pierre Robiquet, already famous for the discovery of alizarin, the most widespread red dye, while working on refined morphine extraction processes. Robiquet is also credited with discovering caffeine independently of Pelletier, Caventou, and Runge. Thomas Anderson determined the correct composition in 1853 but a chemical structure was proposed only in 1925 by J. M. Gulland and Robert Robinson. The first crystal structure would have to wait until 1954.[16–19] WP

Codeine and morphine, as well as opium, were used in an attempt to treat diabetes in the 1880s and thereafter, as recently as the 1950s.[20] WP

Numerous codeine salts have been prepared since the drug was discovered. The most commonly used are the hydrochloride (freebase conversion ratio 0.805, i.e. 10 mg of the hydrochloride salt is equivalent in effect to 8.05 mg of the freebase form), phosphate (0.736), sulphate (0.859), and citrate (0.842). WP

Pharmacology

Pharmacodynamics

Codeine is a nonsynthetic opioid. It is a selective agonist of the μ-opioid receptor (MOR). Codeine itself has relatively weak affinity for the MOR. Instead of acting directly on the MOR, codeine functions as a prodrug of its major active metabolites morphine and codeine-6-glucuronide, which are far more potent MOR agonists in comparison.[73][74][75] WP

Codeine has been found as an endogenous compound, along with morphine, in the brains of nonhuman primates with depolarized neurons, indicating that codeine may function as a neurotransmitter or neuromodulator in the central nervous system. Like morphine, codeine causes TLR4 signaling which causes allodynia and hyperalgesia. It does not need to be converted to morphine to increase pain sensitivity.[76][77] WP

Mechanism of action

Codeine is an opiate and an agonist of the μ-opioid receptor (MOR). It acts on the central nervous system to have an analgesic effect. It is metabolised in the liver to produce morphine which is ten times more potent against the MOR. Opioid receptors are G protein-coupled receptors that positively and negatively regulate synaptic transmission through downstream signalling. Binding of codeine or morphine to the μ-opioid receptor results in hyperpolarization of the neuron leading to the inhibition of the release of nociceptive neurotransmitters, causing an analgesic effect and increased pain tolerance due to reduced neuronal excitability.[78][79] WP

Pharmacokinetics

The conversion of codeine to morphine occurs in the liver and is catalyzed by the cytochrome P450 enzyme CYP2D6. CYP3A4 produces norcodeine, and UGT2B7 conjugates codeine, norcodeine, and morphine to the corresponding 3- and 6-glucuronides. Srinivasan, Wielbo, and Tebbett speculate that codeine-6-glucuronide is responsible for a large percentage of the analgesia of codeine, and thus these patients should experience some analgesia.[80][81] WP

CYP2D6 converts codeine into morphine, which then undergoes glucuronidation. Life-threatening intoxication, including respiratory depression requiring intubation, can develop over a matter of days in patients who have multiple functional alleles of CYP2D6, resulting in ultrarapid metabolism of opioids such as codeine into morphine.[82][83][84] WP

Studies on codeine's analgesic effect are consistent with the idea that metabolism by CYP2D6 to morphine is important, but some studies show no major differences between those who are poor metabolizers and extensive metabolizers. Evidence supporting the hypothesis that ultrarapid metabolizers may get greater analgesia from codeine due to increased morphine formation is limited to case reports.[85] WP

Due to the increased metabolism of codeine to morphine, ultrarapid metabolizers (those possessing more than two functional copies of the CYP2D6 allele) are at increased risk of adverse drug effects related to morphine toxicity. Guidelines released by the Clinical Pharmacogenomics Implementation Consortium (CPIC) advise against administering codeine to ultrarapid metabolizers, where this genetic information is available. The CPIC also suggests that codeine use be avoided in poor metabolizers, due to its lack of efficacy in this group.[86] WP

Codeine and its salts are readily absorbed from the gastrointestinal tract, and ingestion of codeine phosphate produces peak plasma concentrations in about one hour. Plasma half life is between 3 and 4 hours, and oral/intramuscular analgesic potency ratio is approximately equal to 1:1.5. The most common conversion ratio, given on equianalgesia charts used in the United States, Canada, the UK, Republic of Ireland, the European Union, Russia and elsewhere as 130 mg IM equals 200 mg PO—both of which are equivalent to 10 mg of morphine sulphate IV and 60 mg of morphine sulphate PO. The salt:freebase ratio of the salts of both drugs in use are roughly equivalent, and do not generally make a clinical difference.[87] WP

Codeine is metabolised by O- and N-demethylation in the liver to morphine and norcodeine. Hydrocodone is also a metabolite of codeine in humans. Codeine and its metabolites are mostly removed from the body by the kidneys, primarily as conjugates with glucuronic acid.[88][89] WP

The active metabolites of codeine, notably morphine, exert their effects by binding to and activating the μ-opioid receptor. People that can metabolize codeine to an extensive degree could result in a 30 mg dose yielding 4 mg of morphine.[90] WP

Detection

Codeine and its major metabolites may be quantitated in blood, plasma, or urine to monitor therapy, confirm a diagnosis of poisoning, or assist in a medico-legal death investigation. Drug abuse screening programs generally test urine, hair, sweat or saliva. Many commercial opiate screening tests directed at morphine cross-react appreciably with codeine and its metabolites, but chromatographic techniques can easily distinguish codeine from other opiates and opioids. Codeine usage results in significant amounts of morphine as an excretion product. Furthermore, heroin contains codeine (or acetyl codeine) as an impurity and its use will result in the excretion of small amounts of codeine. Poppy seed foods represent yet another source of low levels of codeine in one's biofluids. Blood or plasma codeine concentrations are typically in the 50–300 μg/L range in persons taking the drug therapeutically, 700–7,000 μg/L in chronic users, and 1,000–10,000 μg/L in cases of acute fatal over dosage.[91][92][93] WP

Codeine is produced in the human body along the same biosynthetic pathway as morphine. Urinary concentrations of endogenous codeine and morphine have been found to significantly increase in individuals taking L-DOPA for the treatment of Parkinson's disease.[80] WP

Receptor binding · Wikipedia

Codeine (and metabolite) at opioid receptors

Affinities (Kᵢ (Inhibitor constant))
CompoundMOR (μ-Opioid receptor)DOR (δ-Opioid receptor)KOR (κ-Opioid receptor)MOR:DOR:KOR
Codeine79 nM>1,000 nM>1,000 nMND (No data)[73] WP
Morphine1.8 nM90 nM317 nM1:50:176[74] WP

Chemistry

Formula
C18H21NO3 PC
CAS number
76-57-3 PC
Molar mass (g/mol)
299.4 PC
IUPAC name (computed by PubChem)
(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol PC
SMILES
CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O PC
InChIKey
OROGSEYTTFOCAN-DNJOTXNNSA-N PC
PubChem CID
5284371

User reports

Erowid erowid.org

Listings

Erowid Experience Vault listing TS

Link as published on TripSit's factsheet.

Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Bluelight bluelight.org

Listings
Awaiting sourceTrip report threads and this substance's discussion forum.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Reddit reddit.com

Listings
Awaiting sourceTrip report posts and the relevant subreddits.
Top stories
Awaiting sourceShort summaries of the most-read reports, each linked, saying only what the report says.

Pop culture

No references added yet.

Add a reference

Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.

Opens when accounts launch.

References

  1. Journal / agency Dicpinigaitis, P. V., Morice, A. H., Birring, S. S., McGarvey, L., Smith, J. A., Canning, B. J., Page, C. P. Antitussive Drugs—Past, Present, and Future. Pharmacological Reviews. April 2014. doi:10.1124/pr.111.005116
  2. Journal / agency Codeine analgesia is due to codeine-6-glucuronide, not morphine
  3. Journal / agency Nod and wave: an Internet study of the codeine intoxication phenomenon
  4. Journal / agency Trends and characteristics of accidental and intentional codeine overdose deaths in Australia
  5. Journal / agency Rectal versus oral absorption of codeine phosphate in man
  6. Journal / agency Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism
  7. Other Codeine
  8. Journal / agency Prommer E. Role of codeine in palliative care. Journal of Opioid Management. 2010. doi:10.5055/jom.2011.0081 · PMID 22165039
  9. Journal / agency Paul IM. Therapeutic options for acute cough due to upper respiratory infections in children. Lung. February 2012. doi:10.1007/s00408-011-9319-y · PMID 21892785
  10. Journal / agency Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. The Cochrane Database of Systematic Reviews. November 2014. doi:10.1002/14651858.CD001831.pub5 · PMID 25420096 · PMC7061814
  11. Journal / agency Tobias JD, Green TP, Coté CJ. Codeine: Time to Say "No". Pediatrics. October 2016. doi:10.1542/peds.2016-2396 · PMID 27647717
  12. Other Newton D. Prescription Drug Abuse: A Reference Handbook. 2015
  13. Other Narcotic Drugs 2014. 2015
  14. Other World Health Organization. The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list. 2025
  15. Other http://www.drugs.com/codeine.html
  16. Other Hayes AN, Gilbert SG. Molecular, clinical and environmental toxicology. 2009
  17. Journal / agency Wisniak J. Pierre-Jean Robiquet. Educación Química. 1 March 2013. doi:10.1016/S0187-893X(13)72507-2
  18. Journal / agency Li G, Lou M, Qi X. A brief overview of classical natural product drug synthesis and bioactivity. Organic Chemistry Frontiers. 2022. doi:10.1039/d1qo01341f
  19. Journal / agency Lindsey J, Barnes WH. The Crystal and Molecular Structure of Codeine Hydrobromide Dihydrate. Acta Crystallographica. April 1955. doi:10.1107/S0365110X55000753
  20. Journal / agency Fraser TR. The Relative Value of Opium, Morphine, and Codeine in Diabetes Mellitus. British Medical Journal. January 1889. doi:10.1136/bmj.1.1464.118 · PMID 20752554 · PMC2154578
  21. Other Poisons Standard October 2019
  22. Other Poisons Standard October 2019
  23. Other Poisons Standard October 2019
  24. Other Suchtgiftverordnung
  25. Other Codéine : substance active à effet thérapeutique
  26. Other Anlage III BtMG - Einzelnorm
  27. Other http://gogreece.about.com/od/planagreattriptogreece/a/greecepharmacy_2.htm
  28. Other Laws of Hong Kong, Dangerous Drugs Ordinance, Chapter 134
  29. Wikipedia Wykaz środków odurzających i substancji psychotropowych
  30. Other Kodeina – Narkopedia
  31. Other Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien
  32. Other KIRMIZI REÇETEYE TABİ İLAÇLAR
  33. Other Misuse of Drugs Act 1971
  34. Other Misuse of Drugs Act 1971
  35. Other Unlocking the opium poppy's biggest secret: Genes that make codeine, morphine
  36. Other Merck Index
  37. Other Anonymous Codeine. In The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals; O'Neil, M. J., Ed.; Merck: Whitehouse Station, NJ, 2006; pp 2417
  38. Other International Narcotics Control Board. List of Narcotic Drugs under International Control
  39. Journal / agency Foley M, Harris R, Rich E, Rapca A, Bergin M, Norman I, Van Hout MC. The availability of over-the-counter codeine medicines across the European Union. Public Health. November 2015. doi:10.1016/j.puhe.2015.06.014 · PMID 26215740
  40. Other Over-the-counter Codeine: The End Of An Era, And Preparing For The Changes Ahead
  41. Other Painkillers with codeine won't be available over the counter from 2018. 19 December 2016
  42. Journal / agency McCoy J, Bruno R, Nielsen S. Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication. Drug and Alcohol Review. February 2018. doi:10.1111/dar.12568 · PMID 28597531
  43. Other Letter to Office of Legislative and Regulatory Affairs - Health Canada
  44. Other Chao YS, Severn M. Non-prescription Analgesic and Antitussive Medications Containing Codeine: A Review of Clinical Effectiveness and Safety
  45. Other Legislative Services Branch. Consolidated Federal Laws of Canada, Controlled Drugs and Substances Act. 19 September 2019
  46. Other College of Pharmacists of Manitoba Newsletter Summer 2018
  47. Other Tylenol 1 to require prescription in Manitoba in February 2016
  48. Other Taylor S. 'Opioid epidemic:' Pharmacists want to restrict low-dose codeine products like Tylenol 1
  49. Other Over-the-counter codeine should be limited in wake of 'opioid epidemic', says Sask. pharmacist
  50. Other Recalls and Safety Alerts. 25 August 2021
  51. Journal / agency Foley M, Breindahl T, Hindersson P, Deluca P, Kimergård A. Misuse of 'over-the-counter' codeine analgesics: does formulation play a role?. Public Health. January 2016. doi:10.1016/j.puhe.2015.10.006 · PMID 26612458
  52. Other Koppel K. Pharmacists welcome ban on OTC sale of painkillers containing codeine. 2022-11-23
  53. Journal / agency Baker JL, Shriner D, Bentley AR, Rotimi CN. Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa. The Pharmacogenomics Journal. March 2017. doi:10.1038/tpj.2016.78 · PMID 27779243 · PMC5380847
  54. Other vital list of codein
  55. Other Wilkes D. OTCToolbox - France restricts dextromethorphan and codeine
  56. Other Hong Kong e-Legislation
  57. Other Mudgill A. Pfizer, Abbott shares tank after ban on Corex, Phensedyl and 327 other drugs – The Economic Times. 14 March 2016
  58. Other Codeine regulations cause a few headaches. 8 August 2010
  59. Other Office of the Attorney General
  60. Other Non-Prescription Medicinal Products Containing Codeine: Draft Guidance for Pharmacists
  61. Other Tachidol - Foglio Illustrativo
  62. Other Aneton cough medicine package
  63. Other Nigeria bans all codeine cough syrup. 1 May 2018
  64. Other SA's silent codeine addiction uncovered | IOL News
  65. Other Medicines & Healthcare products Regulatory Agency. Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine. 20 February 2024
  66. Other Misuse of Drugs Act 1971
  67. Other List of most commonly encountered drugs currently controlled under the misuse of drugs legislation. 20 October 2016
  68. Other Misuse of Drugs Act 1971
  69. Other The Misuse of Drugs Regulations 2001. 9 December 2013
  70. Other Valeant Pharmaceuticals. Prescribing Information for Capital with Codeine (paracetamol with codeine) showing Schedule V designation
  71. Other 152.02 Schedules Of Controlled Substances
  72. Other Controlled Substance Schedules. U.S. DEPARTMENT OF JUSTICE, DRUG ENFORCEMENT ADMINISTRATION: Diversion Control Division. link 2
  73. Journal / agency Raynor K, Kong H, Chen Y, Yasuda K, Yu L, Bell GI, Reisine T. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Molecular Pharmacology. February 1994. doi:10.1016/S0026-895X(25)09932-8 · PMID 8114680
  74. Journal / agency Corbett AD, Paterson SJ, Kosterlitz HW. Opioids. 1993. doi:10.1007/978-3-642-77460-7_26
  75. Journal / agency Szucs-Reed RP, Gallagher RM. Handbook of Pain and Palliative Care: Biobehavioral Approaches for the Life Course. 5 January 2012. doi:10.1007/978-1-4419-1651-8_29
  76. Other Neri C; Guama M; et al. Endogenous morphine and codeine in the brain of non human primate. Medical Science Montier 2004, 10, MS1-MS5
  77. Journal / agency Johnson JL, Rolan PE, Johnson ME, Bobrovskaya L, Williams DB, Johnson K, Tuke J, Hutchinson MR. Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation. Translational Psychiatry. November 2014. doi:10.1038/tp.2014.121 · PMID 25386959 · PMC4259992
  78. Journal / agency Papich MG. Saunders Handbook of Veterinary Drugs. 1 January 2016. doi:10.1016/b978-0-323-24485-5.00175-3
  79. Other Hitchings A, Lonsdale D, Burrage D, Baker E. Top 100 drugs: clinical pharmacology and practical prescribing. 2015
  80. Journal / agency Stefano GB, Ptáček R, Kuželová H, Kream RM. Endogenous morphine: up-to-date review 2011. Folia Biologica. 2012. doi:10.14712/fb2012058020049 · PMID 22578954
  81. Journal / agency Srinivasan V, Wielbo D, Tebbett IR. Analgesic effects of codeine-6-glucuronide after intravenous administration. European Journal of Pain. 1997. doi:10.1016/S1090-3801(97)90103-8 · PMID 15102399
  82. Journal / agency Lurcott G. The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone. Anesthesia Progress. 1998. PMID 10483388 · PMC2148980
  83. Journal / agency Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, Desmeules J. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. The New England Journal of Medicine. December 2004. doi:10.1056/NEJMoa041888 · PMID 15625333
  84. Journal / agency Caraco Y. Genes and the response to drugs. The New England Journal of Medicine. December 2004. doi:10.1056/NEJMe048278 · PMID 15625340
  85. Journal / agency Gardiner SJ, Begg EJ. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacological Reviews. September 2006. doi:10.1124/pr.58.3.6 · PMID 16968950
  86. Journal / agency Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, Haidar CE, Shen DD, Callaghan JT, Sadhasivam S, Prows CA, Kharasch ED, Skaar TC. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clinical Pharmacology and Therapeutics. April 2014. doi:10.1038/clpt.2013.254 · PMID 24458010 · PMC3975212
  87. Other The Merck Index, 13th Edition: Morphine Hydrochloride
  88. Journal / agency Cone EJ, Darwin WD, Gorodetzky CW. Comparative metabolism of codeine in man, rat, dog, guinea-pig and rabbit: identification of four new metabolites. The Journal of Pharmacy and Pharmacology. May 1979. doi:10.1111/j.2042-7158.1979.tb13507.x · PMID 37301
  89. Other Codeine Phosphate Tablets 30mg - Summary of Product Characteristics (SmPC) - (emc)
  90. Other Spotlight on Codeine
  91. Journal / agency Thevis M, Opfermann G, Schänzer W. Urinary concentrations of morphine and codeine after consumption of poppy seeds. Journal of Analytical Toxicology. 2003. doi:10.1093/jat/27.1.53 · PMID 12587685
  92. Journal / agency Cone EJ, Welch P, Paul BD, Mitchell JM. Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration. Journal of Analytical Toxicology. 1991. doi:10.1093/jat/15.4.161 · PMID 1943064
  93. Other Baselt R. Disposition of Toxic Drugs and Chemicals in Man. 2008

Text and values on this page are quoted from PsychonautWiki (CC BY-SA 4.0), Wikipedia (CC BY-SA 4.0), TripSit factsheets, PubChem (public domain). Each value links to the exact revision it came from.